1Mary F. Dillon MB, MRCSI,Arnold D. K. Hill MCh, FRCSI,Cecily M. Quinn MD, FRCPI, FRCPath,Enda W. McDermott MCh, FRCSI,Niall O’Higgins MCh, FRCSI.A Pathologic Assessment of Adequate Margin Status in Breast-Conserving Therapy[J].Annals of Surgical Oncology.2006(3)
2Cabioglu N,Hunt K K,Buchholz TA,et al.Improving local control with breast-conserving therapy a27-year single-institution experience[].Cancer.2005
3Jolly S,Kestin L L,Goldstein N S,et al.The Impact of lobular carcinomain situin association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy[].International Journal of Radiation Oncology Biology Physics.2006
4Fleminga F J,Hill A D,Mc Dermott EW,et al.Intraoperative margin assessment and re-excision rate in breast conservingsurgery[].European Journal of Surgical Oncology.2004
5Scopa CD,Aroukatos P,Tsamandas AC,et al.Evaluation ofmargin status in lumpectomy specimens and residual breast carci-noma[].Breast Journal.2006
6LEONG C,BOYAGES J,JAYASINGHE UW,ET AL.EFFECT OF MARGINS ON IPSILATERAL BREAST TUMOR RECURRENCE AFTER BREAST CONSERVATION THERAPY FOR LYMPH NODE-NEGATIVE BREAST CARCINOMA[].Cancer.2004
7Fowble BL,Schultz DJ,Overmoyer B,et al.The influence of young age on outcome in early stage breast cancer[].International Journal of Radiation Oncology Biology Physics.1994
8Jackson,SM.Carcinoma of the breast: The significance of supraclavicular lymph node metastases[].Clinical Radiology.1966
9Kurtz,JM,Jacquemier,J,Amalric,R,Brandone,H,Ayme,Y,Hans,D,Bressac,C,Spitalier,JM.Why are local recurrences after breast-conserving therapy more frequent in younger patients?[].Journal of Clinical Oncology.1990
10Perez CA.Conservation therapy in T1-T2 breast cancer: past, current issues, and future challenges and opportunities[].Cancer Journal.2003
